Drug intelligence / Profile preview

Keli-med

Development stage
Unknown
Lead developer
Permamed
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Keli-med is a topical scar treatment cream developed and marketed by Permamed. It is formulated with a synergistic combination of active ingredients designed to promote optimal scar healing, prevent hypertrophic scar and keloid formation, and protect healing tissue from ultraviolet radiation. The active components include onion extract (Allii cepae extractum), which inhibits fibroblast function and exerts fibrinolytic effects; hyoscyamus oil macerate (henbane oil), traditionally used to soothe and treat scars; allantoin, which promotes tissue hydration and regeneration; and heparin sodium, which provides antithrombotic, anti-inflammatory, and analgesic properties while facilitating tissue resorption. Additionally, Keli-med contains the UV-A filter avobenzone and the UV-B filter enzacamene to protect melanin-deficient scar tissue from sun damage. It is indicated for the prophylaxis and treatment of hypertrophic scars and keloids resulting from surgeries, skin transplants, burns, and other injuries.

Brand names
Keli-medKeli-med Creme
Other names
allantoin + avobenzone + enzacamene + heparin sodium + hyoscyamus oil macerate + onion extract
02

Targets

ATIII (Antithrombin III)

Beyond the preview

Go deeper on Keli-med.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keli-med.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call